MAI Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.2K Buy
6,217
+2,037
+49% +$15.3K ﹤0.01% 2421
2025
Q4
$30K Sell
4,180
-631
-13% -$4.99K ﹤0.01% 2300
2025
Q3
$51.4K Sell
4,811
-806
-14% -$7.91K ﹤0.01% 1910
2025
Q2
$54.4K Buy
5,617
+38
+0.7% +$392 ﹤0.01% 1805
2025
Q1
$83.1K Buy
5,579
+410
+8% +$6.3K ﹤0.01% 1488
2024
Q4
$77.1K Buy
+5,169
New +$84.2K ﹤0.01% 1555
2024
Q3
Sell
-26,529
Closed -$549K 1204
2024
Q2
$549K Buy
26,529
+16,100
+154% +$320K 0.01% 775
2024
Q1
$196K Buy
+10,429
New +$179K ﹤0.01% 1128
2022
Q2
Sell
-5,921
Closed -$207K 947
2022
Q1
$207K Buy
+5,921
New +$202K ﹤0.01% 816
2021
Q4
Sell
-7,032
Closed -$231K 947
2021
Q3
$231K Sell
7,032
-551
-7% -$17.6K ﹤0.01% 687
2021
Q2
$229K Buy
+7,583
New +$250K ﹤0.01% 671

Other funds holding OGN

MAI Capital Management's OGN Position: Q1 2026 in Review

MAI Capital Management increased its Organon & Co (OGN) stake by 49% in Q1 2026, buying an estimated $15.3K and bringing the position to 6,217 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2421.

MAI Capital Management first reported a position in OGN in Q2 2021 and has held it in 11 quarters since. The position peaked at $549K in Q2 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • MAI Capital Management held 6,217 shares of Organon & Co worth $37.2K as of Q1 2026.
  • MAI Capital Management bought 2,037 Organon & Co shares in Q1 2026, an estimated $15.3K.
  • Organon & Co made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #2421 holding.
  • MAI Capital Management first reported a position in Organon & Co in Q2 2021 and has held it in 11 quarters since.
  • MAI Capital Management's Organon & Co position peaked at $549K in Q2 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.